Impact of LAA Exclusion on Neurohormonal Modulation

Atrial Fibrillation: Scope of the Problem

Differences Between US and Japan in OAT Discontinuation and Risk of Major Bleeds, and Who are the Best LAA Closure Device Candidates in Both Countries

Cases #7 and #8: When LAA closure Was Unsuccessful - Lessons Learned

Cases #1 and #2: Insights From Baseline Imaging - When to Try and When to Walk Away

Appropriate Use Criteria of LAA Closure Devices: PMDA’s View

Appropriate Use Criteria of LAA Closure Devices: US Industry View

Debate #2: Is LAA Closure Preferred First-line Treatment in Patients With Recent Stents or ACS? Yes – Minimize Bleeding Risk and Improve Long-term Outcomes!

Early and Late Results With the Occlutech LAA Occluder (and Future studies)

Early and Late Results With the Wavecrest LAA Occluder (and Future Studies)